z-logo
Premium
CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells
Author(s) -
Chen Xiong,
Mo Ping,
Li Xiaohua,
Zheng Peichan,
Zhao Lina,
Xue Zengfu,
Ren Gui,
Han Guohong,
Wang Xin,
Fan Daiming
Publication year - 2011
Publication title -
molecular carcinogenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.254
H-Index - 97
eISSN - 1098-2744
pISSN - 0899-1987
DOI - 10.1002/mc.20737
Subject(s) - pancreatic cancer , biology , carcinogenesis , cancer research , cyclin e , cancer cell , ubiquitin , retinoblastoma protein , cancer , microbiology and biotechnology , cell cycle , cyclin , biochemistry , genetics , gene
Calcyclin‐binding protein or Siah‐1‐interacting protein (CacyBP/SIP), a component of the ubiquitin‐mediated proteolysis, could participate in beta‐catenin degradation, which was found to be related to the malignant phenotypes of pancreatic cancer previously. However, the role of CacyBP/SIP itself in pancreatic cancer has not been investigated. In the present study, CacyBP/SIP expression was assayed and manipulated to reveal the potential mechanism in pancreatic cancer carcinogenesis. Here, we show that CacyBP/SIP is over‐expressed in pancreatic cancer cells. Down‐regulation of CacyBP/SIP by small interference RNA (siRNA) severely suppresses the proliferation and tumorigenesis in pancreatic cancer. G1/S transition arrest induced by inhibition of CacyBP/SIP is at least partly mediated by down‐regulation of Cyclin E and CDK2 as well as up‐regulation of p27 and Rb. Collectively, CacyBP/SIP as an enhancer of pancreatic cancer malignance might develop into another possible therapeutic target. Mol. Carcinog. © 2011 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom